Erwin Lamping

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsDental therapeutics, pharmacology and toxicologyMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2026
G521 is the gatekeeper and a key transmembrane domain contact residue of Candida albicans Cdr1.

Mengcun Zhao, Masakazu Niimi, Kyoko Niimi

|Nov 26, 2025
Molecular Mechanism of Action of HOCl from Neutral-pH Electrolysed Oxidising Water Against Candida albicans.

Chitra S Krishnan, Trudy J Milne, Geoffrey R Tompkins

|Oct 27, 2022
Voriconazole Treatment Induces a Conserved Sterol/Pleiotropic Drug Resistance Regulatory Network, including an Alternative Ergosterol Biosynthesis Pathway, in the Clinically Important FSSC Species, Fusarium keratoplasticum.

Jasper E James, Jacinta Santhanam, Richard D Cannon

|Aug 26, 2022
Morphology, Phenotype, and Molecular Identification of Clinical and Environmental Fusarium solani Species Complex Isolates from Malaysia.

Jasper E James, Jacinta Santhanam, Latiffah Zakaria

|Nov 15, 2021
Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.

Masakazu Niimi, Kyoko Niimi, Koichi Tanabe

|Feb 11, 2021
Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1.

Golnoush Madani, Erwin Lamping, Richard D Cannon

Pageof 2

Frequent Collaborators

7 joint publications

Richard David Cannon

1 joint publications

Masakazu Niimi

1 joint publications

Latiffah Zakaria

1 joint publications

Jasper E James